Archive for January 21st, 2010

A new drug for multiple sclerosis promises to change the lives of the 100,000 people in the UK who have the condition, say researchers at Queen Mary, University of London…

Clinical trial results for the tablets being developed for multiple sclerosis (MS) will be published in the latest issue of the New England Journal of Medicine. The studies suggest that the oral therapies, potentially the first of their kind for relapsing remitting MS, are at least as effective as current drugs on the market and could be available as early as next year…